2022
DOI: 10.20944/preprints202203.0018.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Investigating the Potential Use of Chemical Biopsy Devices to Characterize Brain Tumor Lipidomes

Abstract: The development of a fast and accurate intraoperative method that enables the differentiation and stratification of cancerous lesions is still a challenging problem in laboratory medicine. Therefore, it is important to find and optimize a simple and effective analytical method that enables the selection of distinctive metabolites. This study aims to assess the usefulness of solid-phase microextraction (SPME) probes as a sampling method for the lipidomic analysis of brain tumors. To this end, SPME was applied t… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 56 publications
0
1
0
Order By: Relevance
“…Although the relative concentration obtained from the intact tissue corresponded to the concentration measured in the homogenate (calculated based on the standard addition method), several issues should be discussed prior to further attempts to develop the calibration strategy for determining endogenous compounds in cancer tissue with CBS-MS. First, since brain tumors are characterized by high heterogeneity, the homogenization of a small section may only result in the selection of a portion of the tumor's phenotype [22]. Conversely, SPME probes enable the extraction of analytes along the sorbent from various parts of the tumor [30]. Secondly, the CBS-MS device has a bigger extraction surface than SPME fibers, which means that it can be influenced more easily by the composition of a changed region (e.g., the calcified part of the tumor where extraction is altered at a specific part of the blade).…”
Section: Resultsmentioning
confidence: 99%
“…Although the relative concentration obtained from the intact tissue corresponded to the concentration measured in the homogenate (calculated based on the standard addition method), several issues should be discussed prior to further attempts to develop the calibration strategy for determining endogenous compounds in cancer tissue with CBS-MS. First, since brain tumors are characterized by high heterogeneity, the homogenization of a small section may only result in the selection of a portion of the tumor's phenotype [22]. Conversely, SPME probes enable the extraction of analytes along the sorbent from various parts of the tumor [30]. Secondly, the CBS-MS device has a bigger extraction surface than SPME fibers, which means that it can be influenced more easily by the composition of a changed region (e.g., the calcified part of the tumor where extraction is altered at a specific part of the blade).…”
Section: Resultsmentioning
confidence: 99%